24 July 2024
24 July 2024
The Israeli company said it is preparing for pivotal trials in the US as it eyes FDA approval in mechanical circulatory support indications.
Driven by the Covid-19 pandemic, the healthcare sector digitalised rapidly, uncovering new and lingering cybersecurity risks.
The miniature robotic system introduces substantial new capabilities, including the TMINI PRO workflow.
Ceribell's EEG monitoring device reduces the average length of an ICU stay by four days, with fewer patients leaving the ICU with disabilities, compared to conventional EEG.
The FloPatch hands-free device can measure blood flow and heart function in relation to IV fluid volume.
The company’s urinary incontinence implant met the primary endpoint in the device trial, with Neuspera now looking to submit the data to the FDA.
The device employs advanced algorithms to determine when white blood cell levels become critically low.
The SPIRA-A Integrated device is indicated for use at one or more levels from L1-S1 in skeletally mature patients.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
